Every year, smokers across the nation take part in the American Cancer Society's Great American Smokeout® by smoking less or quitting for the day on the third Thursday of November. The event challenges people to stop using tobacco and raises awareness of the many effective ways to quit for good. In many communities, local volunteers support quitters, publicize the event, and press for laws that control tobacco use and discourage teenagers from starting.
In America, in 2004, there were 45 million cigarette smokers (about 20.9% of the population). The Healthy People 2010 goal is to decrease the percent of cigarette smokers to 12% by 2010. Research shows that smokers are most successful in kicking the habit when they have some means of support, such as nicotine replacement products, counseling, prescription medicine to lessen cravings, guide books, and the encouragement of friends and family members.
Despite that, only about 1 in 7 current smokers reports having tried any of the recommended therapies during his or her last quit attempt. And only about 5% of the people that quit 'cold turkey' are permanently successful
The Smokeout has helped bring about dramatic changes in Americans' attitudes about smoking, which have led to community programs and smoke-free laws that are now saving lives in many states. The event began in the 1970s when smoking and secondhand smoke were commonplace. The idea for the Great American Smokeout grew out of a 1974 event. Lynn R. Smith, editor of the Moticello Times in Minnesota, spearheaded the state's first DDay, or Don't Smoke Day. The idea may have been inspired by Arthur P. Mullaney of Randolph, Massachusetts, who three years earlier had asked people to give up cigarettes for a day and donate the money they would have spent on cigarettes to a high school scholarship fund.
Included in this edition of the Newsletter are two articles that should be of interest to all pharmacists.
Great location! Beautiful hotel! Gorgeous facilities! These were just a few of the comments from the over 200 attendees at the VSHP 2007 Fall Seminar. The remarks were about the new Hampton Roads Convention Center and the adjoining Embassy Suites Hotel located in Hampton, VA. Although the venue was superb, the programming was even better. However, the social and networking opportunities topped even that! Mixed in with the usual programming and exhibits were several new activities. This year marked the return of the poster session that will get bigger and better each year as pharmacists and technicians alike gear up for presentations.
Also new this year was the Political Action Committee [PAC] Silent Auction. Everyone loved this enhancement to the meeting! Bidding wars arose as attendees plied their skills at outbidding one another while trying to remain well below the actual retail value of the prize. Several vacation packages were included in the auction along with gift cards, gift baskets, paintings, antique pharmacy items, and bric-a-brac. In the end, everyone was happy and still friends, plus over $3,500 was raised for our PAC. VSHP is proud to say the every item up for auction sold. Not to be forgotten or shunned, the meeting program was exceptional too. VSHP provided 15 contact hours [1.5 CEUs], an increase from last year's offering.
The meeting activities began on Thursday, October 4 th with the PAC Board of Trustees Meeting. The Trustees reviewed all of the 2007 upcoming elections and approved contributions to select candidates that would further the VSHP mission. In addition, they approved a permanent home for the annual PAC Silent Auction to be held in conjunction each year with the Spring Seminar.
The VSHP Board of Directors Meeting began at 1:00pm and continued until 5:00pm. Per standing protocol, any person in the general membership is invited, and encouraged, to attend this meeting. Several members took advantage of this offer. At the Board of Directors meeting, the need for an individual to serve as Chair of Communications and to coordinate the submission of materials for the VSHP newsletter and website was identified. We are seeking a person to identify timely topics for incorporation into the website and newsletter. Please contact Michelle McCarthy (mm4tm@virginia. edu) if you are interested in this position. Also, members who have news items, either professional or personal, to contribute to the newsletter should send information to Carl Tullio (carl.tullio@ pfizer.com). Our last newsletter highlighted 2007 appointments to ASHP Councils/ Committees. However, we know that there are members who are already serving ASHP in other capacities. It was also decided to offer an electronic version of the newsletter. You will note on the December renewal notices, you have the opportunity to select which form of newsletter you would like to receive.
After the Board meeting, the PastPresidents' Cocktail Reception and Banquet was held. This incredible evening was sponsored by Roche and offered an elegant evening of fun and reminiscing designed to honor those pharmacy lead- For payment to be received for outpatient prescription drugs, including over-the counter products, the law requires non-electronic prescriptions be written on a tamperresistant paper. The law applies regardless of whether Medicaid is the primary or secondary payor of the prescription. The law does not apply when: a managed care entity pays for the prescription, the prescription is electronically transmitted or faxed to the pharmacy, or is communicated by telephone from the prescriber to the pharmacy. To be considered tamper-resistant, the paper must contain at least one of the following characteristics: 1. one or more features designed to prevent unauthorized copying 2. one or more features designed to prevent erasure or modification of information written by the prescriber 3. one or more features designed to prevent the use of counterfeit prescription forms On October 1, 2008, for a prescription to be judged tamper-resistant, all three characteristics will be required. Pharmacists, prescribers, and several professional societies expressed their concerns regarding the limited timeframe for implementation. The primary concern was that Medicaid beneficiaries would not be able to obtain their medications. Along with the National Association of Chain Drug Stores (NACDS) and the American Pharmacists Association (APhA), members of the American Society of Health-System Pharmacists (ASHP) participated in a campaign requesting a delay in the implementation of tamper-resistant prescription pads. Additionally, members of ASHP worked with the offices of Representative Charlie Wilson and Senator Sherrod Brown, both from Ohio, to raise awareness among lawmakers. More than 90 legislators signed a "Dear Colleague" letter requesting a delay in the implementation.
The fruits of this campaign were first observed on Wednesday, September 26 when the U.S. House of Representatives passed a bill delaying implementation. Later that day, the U.S. Senate passed a similar measure. ASHP members who participated in Legislative Day had the opportunity to thank their representatives on September 27. President Bush signed the legislation into law on Friday, September 28, 2007. This success resulted in a six-month delay allowing until March 31, 2008 for implementation of the tamper-resistant requirement.
The results of this campaign demonstrate the power of society membership and professional collaboration. It is imperative that we continuously work together in our practice settings and through our professional societies and legislative initiatives to improve patient care. In February, VSHP members will spend a day at the Commonwealth's Capitol for our Annual Lobby Day. Consider joining us for your opportunity to make a difference. 
Specialty Area of Practice 
*If applying for joint membership, please complete an application form for self and spouse. If applying for student membership, please include a photocopy of current student I.D.
Send completed application and check made payable to VSHP to P.O. Box 2567, Fairfax, VA 22031-2567.
Cigarette use is the leading preventable cause of death in the United States (1). A national health objective for 2010 is to reduce the prevalence of current cigarette use among high school students to <16% (objective no. 27-2b) (1). To examine changes in cigarette use among high school students in the United States during 1991-2005, CDC analyzed data from the national Youth Risk Behavior Survey (YRBS). This report summarizes the results of that analysis, which indicated that, although lifetime, current, and current frequent cigarette use was stable or increased during the 1990s and then decreased significantly from the late 1990s to 2003, prevalence was unchanged during [2003] [2004] [2005] . To achieve the 2010 objective, the downward trend in youth smoking must resume.
The biennial national YRBS, a component of CDC's Youth Risk Behavior Surveillance System, used independent, three-stage cluster samples for the 1991-2005 surveys to obtain cross-sectional data representative of public and private school students in grades 9-12 in all 50 states and the District of Columbia. Sample sizes ranged from 10,904 to 16,296. For each cross-sectional national survey, students completed anonymous, self-administered questionnaires that included identically worded questions about cigarette use. School response rates ranged from 70% to 81%, and student response rates ranged from 83% to 90%; therefore, overall response rates for the surveys ranged from 60% to 70%.
For this analysis, temporal changes for three behaviors were assessed: lifetime cigarette use (i.e., ever tried cigarette smoking, even one or two puffs), current cigarette use (i.e., smoked cigarettes on >1 of the 30 days preceding the survey), and current frequent cigarette use (i.e., smoked cigarettes on >20 of the 30 days preceding the survey). Race/ethnicity data are presented only for non-Hispanic black, nonHispanic white, and Hispanic students (who might be of any race); the numbers of students from other racial/ethnic groups were too small for meaningful analysis.
Data were weighted to provide national estimates, and the statistical software used for all data analyses accounted for the complex sample design. Temporal changes were analyzed using logistic regression analyses, which controlled for sex, race/ethnicity, and grade and also simultaneously assessed linear and quadratic time effects. Quadratic trends indicate a significant but nonlinear trend in the data over time (e.g., a leveling off or statistically significant change in direction). Trends that include significant quadratic and linear components demonstrate nonlinear variation in addition to an overall increase or decrease over time. Differences in lifetime, current, and current frequent cigarette use comparing 2003 with 2005 were assessed for statistical significance using t tests.
Significant linear and quadratic trends were detected for lifetime, current, and current frequent cigarette use. The six major conclusions of the latest report are as follows:
1. Secondhand smoke causes premature death and disease in children and in adults who do not smoke.
2. Children exposed to secondhand smoke are at an increased risk for sudden infant death syndrome (SIDS), acute respiratory infections, ear problems, and more severe asthma. Smoking by parents causes respiratory symptoms and slows lung growth in their children.
3. Exposure of adults to secondhand smoke has immediate adverse effects on the cardiovascular system and causes coronary heart disease and lung cancer.
The scientific evidence indicates that
there is no risk-free level of exposure to secondhand smoke.
5. Many millions of Americans, both children and adults, are still exposed to secondhand smoke in their homes and workplaces despite substantial progress in tobacco control. 
Eliminating smoking in indoor spaces

Publication of Surgeon General's Report
The Health Consequences of Involuntary Exposure to Tobacco Smoke rolled in a high school program and had not completed high school (8) . Second, the extent of underreporting or overreporting behaviors cannot be determined, although the survey questions have demonstrated good test-retest reliability (9).
The national health objective for 2010 of reducing current cigarette use among high school students to <16% to reduce smoking-associated morbidity and mortality can be achieved only if the annual rate of decline observed during 1997-2003 resumes. Evidence-based strategies that can increase the rate of decline in youth smoking include greater exposure to effective media campaigns, comprehensive school-based tobacco-use prevention policies and programs in conjunction with supportive community activities, and higher retail prices for tobacco products (10) .
ers who have served our society as President.
The educational portion of the meeting began with a CE breakfast sponsored by sanofi-aventis. Exhibit programs were held twice on Friday, during the lunch break and, again, in the evening before the Annual Awards Reception. These sessions allowed all attendees to meet and greet the exhibitors and to learn about the latest in medicines, dispensing systems, and technology advances. Additionally, this relaxed setting provided an excellent opportunity for renewing old friendships and networking with new friends. The Poster Session ran concurrently with the evening exhibit session.
With lunch over, the educational programming resumed. 
VSHP Award Winners
Pharmacist of the Year: Arash Dabestani, PharmD, MHA, is the pharmacy director at Potomac Hospital. He recently completed the daunting task of designing pharmacy facilities and services for the new Potomac hospital. These responsibilities included concepts for introducing automation using the Mckesson Robot and Acudose-RX machines, devising methods for providing medications to patients via labor intensive Nurse Servers, and undertaking the design and implementation of policies and procedures to assure U.S.P. 797 compliance. Arash established regular meetings for pharmacy leaders in the Washington, D.C. area to discuss common areas of concern, complete with speakers on a myriad of timely topics. However, his greatest accomplishment was establishing www.Pharmacydirectors.com , the first web based comprehensive resource for Directors of Pharmacy world wide. Through various links, topics such as Robotics, Patient Safety, Disaster Preparedness, Legal Issues and, of course, Joint Commission, are addressed to assist practitioners world wide and save them from having to re-invent the wheel. Now the experience of others can be shared instantly with those facing the same challenges in the ever changing world of Pharmacy. expanding inpatient clinical programs and establishing medication therapy management services based in physician practices. Janet has focused on the application of technology and automation to enhance medication safety and has presented often on this topic. Janet Silvester holds a B.S. in Pharmacy from the Medical College of Virginia, a Masters in Business Administration from James Madison University, and is currently enrolled in an external Doctor of Pharmacy program through Creighton University. Janet has served ASHP as a member of the Board of Directors, Foundation Development Committee, Chair of the Council on Legal and Public Affairs and as a Virginia delegate. Janet is the current ASHP President. She is also a past-president of VSHP. Janet has received several honors including the Virginia Society's Health-System Pharmacist of the Year award.
R.D. Anderson Distinguished
Clinical Pharmacist of the Year:
Shelly Collins currently serves as Clinical Pharmacy Coordinator at Chesapeake General Hospital in Chesapeake, VA. As a side job, she works as an expert defense witness for various legal firms. She graduated with a PharmD and completed a clinical pharmacy residency in California. Shelly is responsible of monitoring all adverse drug reactions that occur with the hospital. A 'near miss' in a young healthy patient that underwent elective surgery but experienced respiratory arrest from narcotics and nearly died led her to do a root cause analysis of this event. She found similar events, including death, occurred in usually obese patients with obstructive sleep apnea that had a history of snoring. Shelly spearheaded a drive to increase awareness of this problem, purchase End Tidal CO 2 monitors, and had all post-op patients at risk monitored to prevent respiratory arrest. To date, seven patients were provided intervention to avoid respiratory arrest. 
New Practitioner of the
